Skip to main content
SpringerLink
Log in

Age and gender may affect posterior reversible encephalopathy syndrome in renal disease

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

It remains elusive what factors affect posterior reversible encephalopathy syndrome (PRES). Eleven PRES children, all with acute glomerulonephritis, Alport syndrome, and lupus nephritis, 5 with nephrosis, and 3 renal transplant recipients, were studied. PRES recurred in 1 patient. Neurological symptoms were graded as 1: mild (headache, nausea/vomiting, or tremor), 2: moderate (vision change), and 3: severe (mental dysfunction, cerebellar symptoms, seizures, recurrence of seizures, and coma). Magnetic resonance imaging was graded as 1: subtle change, 2: abnormal large areas, and 3: complete involvement of the regions. The common symptoms were seizures (100%), headache (82%), nausea/vomiting (73%), coma (55%), and vision change (46%). Seizures recurred in 7 (64%). All but one (91%) developed hypertension and 7 (64%) received calcineurin inhibitors (CNI). Edema occurred in 7 (64%) and renal insufficiency/end-stage renal disease (ESRD) in 4 (36%). Seizures recurred frequently in younger patients. Symptoms were severe in girls. Duration or severity of the condition with predisposing factors (hypertension, CNI, nephrosis or renal insufficiency/ERSD) did not make a difference in the symptoms and neuroimaging. Two patients developed chronic epilepsy. Age and gender may affect PRES symptoms. Our results are limited by small sample size and should be determined using larger numbers of patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, Pessin M, Lamy C, Mas JL, Caplan LR (1996) A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334:494–500

    Article  PubMed  CAS  Google Scholar 

  2. Bartynski WS (2008) Posterior reversible encephalopathy syndrome. I. Fundamental imaging and clinical features. AJNR Am J Neuroradiol 29:1036–1042

    Article  PubMed  CAS  Google Scholar 

  3. Bartynski WS (2008) Posterior reversible encephalopathy syndrome. II. Controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 29:1043–1049

    Article  PubMed  CAS  Google Scholar 

  4. Fugate JE, Claassen DO, Cloft HJ, Kallmes DF, Kozak OS, Rabinstein AA (2010) Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings. Mayo Clin Proc 85:427–432

    Article  PubMed  Google Scholar 

  5. Roth C, Ferbert A (2010) Posterior reversible encephalopathy syndrome: long-term follow-up. J Neurol Neurosurg Psychiatry 81:773–777

    Article  PubMed  Google Scholar 

  6. De Laat P, te Winkel ML, Devos AS, Catsman-Berrevoets CE, Pieters R, van den Heuvel-Eibrink MM (2011) Posterior reversible encephalopathy syndrome in childhood cancer. Ann Oncol 22:472–478

    Article  PubMed  Google Scholar 

  7. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Shishido S, Asanuma H, Nishimura G, Hiramoto R, Honda M (2006) Posterior reversible encephalopathy syndrome in children: its high prevalence and more extensive imaging findings. Am J Kidney Dis 48:231–238

    Article  PubMed  Google Scholar 

  8. Ishimori ML, Pressman BD, Wallace DJ, Weisman MH (2007) Posterior reversible encephalopathy syndrome: another manifestation of CNS SLE? Lupus 16:436–443

    Article  PubMed  CAS  Google Scholar 

  9. Onder AM, Lopez R, Teomete U, Francoeur D, Bhatia R, Knowbi O, Hizaji R, Chandar J, Abitbol C, Zilleruelo G (2007) Posterior reversible encephalopathy syndrome in the pediatric renal population. Pediatr Nephrol 22:1921–1929

    Article  PubMed  Google Scholar 

  10. Ikeda M, Ito S, Hataya H, Honda M, Anbo K (2001) Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis 37:E30

    Article  PubMed  CAS  Google Scholar 

  11. Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, Honda M (2008) Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transplant 23:2531–2536

    Article  PubMed  Google Scholar 

  12. Saeed B, Abou-Zor N, Amer Z, Kanani I, Hilal M (2008) Cyclosporin-A induced posterior reversible encephalopathy syndrome. Saudi J Kidey Dis Transpl 19:439–442

    Google Scholar 

  13. Nishida M, Sato H, Kobayashi N, Morimoto M, Hamaoka K (2009) Wernicke’s encephalopathy in a patient with nephrotic syndrome. Eur J Pediatr 168:731–734

    Article  PubMed  Google Scholar 

  14. Kabicek P, Sulek S, Seidl Z, Vaneckova M, Kabickova E, Vobruba V, Wenchich L, Zeman J (2010) Posterior reversible encephalopathy syndrome (PRES) in 5-year-old girl with nephrotic syndrome. Neuro Endocrinol Lett 31:297–300

    PubMed  Google Scholar 

  15. Akutsu N, Iwashita C, Maruyama M, Ootsuki K, Ito T, Saigo K, Kenmochi T (2008) Two cases of calcineurin inhibitor-associated reversible posterior leukoencephalopathy syndrome in renal transplant recipients. Transpl Proc 40:2416–2418

    Article  CAS  Google Scholar 

  16. Gijtenbeek JMM, van den Bent MJ, Vecht CJ (1999) Cyclosporine neurotoxicity: a review. J Neurol 246:339–346

    Article  PubMed  CAS  Google Scholar 

  17. Mueller-Mang C, Mang T, Pirker A, Klein K, Prchla C, Prayer D (2009) Posterior reversible encephalopathy syndrome: do predisposing factors make a difference in MRI appearance? Neuroradiology 51:373–383

    Article  PubMed  Google Scholar 

  18. Bartynski WS, Boardman JF, Zeigler ZR, Shadduck RK, Lister J (2006) Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 27:2179–2190

    PubMed  CAS  Google Scholar 

  19. Bechstein WO (2000) Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transplant Int 13:313–326

    Article  CAS  Google Scholar 

  20. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents (2004) The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114:555–576

    Article  Google Scholar 

  21. Awan AQ, Lewis MA, Postlethwaite RJ, Webb NJA (1999) Seizures following renal transplantation in childhood. Pediatr Nephrol 13:275–277

    Article  PubMed  CAS  Google Scholar 

  22. Zheng W (2001) Neurotoxicology of the brain barrier system: new implications. Clin Toxicol 39:711–719

    Article  CAS  Google Scholar 

  23. Tuor UI, Grewal D (1994) Autoregulation of cerebral blood flow: influence of local brain development and postnatal age. Am J Physiol 267:H2220–H2228

    PubMed  CAS  Google Scholar 

  24. Ducros A, Fiedler U, Porcher R, Boukobza M, Stapf C, Bousser MG (2010) Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke 41:2505–2511

    Article  PubMed  Google Scholar 

  25. Schmithorst VJ, Holland SK, Dardzinski BJ (2008) Developmental differences in white matter architecture between boys and girls. Hum Brain Mapp 29:696–710

    Article  PubMed  Google Scholar 

  26. Besenski N, Rumboldt Z, Emovon O, Nicholas J, Kini S, Milutinovic J, Budisavljevic MN (2005) Brain MR imaging abnormalities in kidney transplant recipients. AJNR Am J Neuroradiol 26:2282–2289

    PubMed  Google Scholar 

  27. Irvin W, MacDonald G, Smith JK, Kim WY (2007) Dexamethasone-induced posterior reversible encephalopathy syndrome. J Clin Oncol 25:2484–2486

    Article  PubMed  Google Scholar 

  28. Bai JPF, Lesko LJ, Burckart GJ (2010) Understanding the genetic basis for adverse effects: the calcineurin inhibitors. Pharmacotherapy 30:195–209

    Article  PubMed  CAS  Google Scholar 

  29. Pirker A, Kramer L, Voller B, Loader B, Auff E, Prayer D (2011) Type of edema in posterior reversible encephalopathy syndrome depends on serum albumin levels: an MR imaging study in 28 patients. AJNR Am J Neuroradiol 32:527–531

    Article  PubMed  CAS  Google Scholar 

  30. Girişgen İ, Tosun A, Sönmez F, Özsunar Y (2010) Recurrent and atypical posterior reversible encephalopathy syndrome in a child with peritoneal dialysis. Turkish J Pediatr 52:416–419

    Google Scholar 

  31. Prasad N, Gulati S, Gupta RK, Kumar R, Sharma K, Sharma RK (2003) Is reversible posterior leukoencephalopathy syndrome with severe hypertension completely reversible in all patients? Pediatr Nephrol 18:1161–1166

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Drs K. Tsuzuki, M. Shibata, M. Atsumi, Y. Nagano, T. Hiraiwa, and A. Tashiro for taking care of the patients.

Author information

Authors and Affiliations

  1. Department of Pediatrics, Social Insurance Chukyo Hospital, Nagoya, Aichi, Japan

    Akio Yamada

  2. Department of Developmental Pediatrics, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan

    Norishi Ueda

Authors
  1. Akio Yamada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norishi Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norishi Ueda.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamada, A., Ueda, N. Age and gender may affect posterior reversible encephalopathy syndrome in renal disease. Pediatr Nephrol 27, 277–283 (2012). https://doi.org/10.1007/s00467-011-1974-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-011-1974-y

Keywords

Search

Navigation